Glaucoma

Top Story

VIDEO: Hydrus looks to be next MIGS device in US market

November 15, 2017

NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Dave Van Meter, president and CEO of Ivantis, discusses the Hydrus microstent, which has a “trimodal” mechanism of action to lower IOP in patients with glaucoma.

Meeting News

Global outreach gives hope to those with treatable blindness

November 14, 2017
NEW ORLEANS — New technologies are aiding global outreach programs to help the millions of people worldwide who are blind, according to Alan S. Crandall, MD, who…

OCT screening in internal medicine increases disease detection

Primary Care Optometry News, November 2017
Jerome Sherman, OD, FAAO
It is no surprise that patients without a significant refractive error may wait until their 50s or even 60s before obtaining a comprehensive eye exam. Presbyopia in an…
Meeting News

Hydrus canal stent meets study endpoint

November 13, 2017
NEW ORLEANS — Two-year results of the HORIZON study show that 77.2% of patients implanted with a Hydrus microstent achieved the primary endpoint of a 20% reduction…
More Headlines »
CME COPE

Ocular Surface Diseases, Disorders, and Dysfunctions™: Volume 3, Number 2

This activity is supported by an educational grant from Shire.

Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to…
More »
Video
Meeting News

VIDEO: Mitro updates Roclatan studies, Aerie financing

June 26, 2017
More »
Resource Centers
American Academy of Optometry

American Academy of Optometry

Video
Meeting News

VIDEO: Surgeon should make IOL recommendation to patients

October 30, 2017
More »
Advertisement
Advertisement